Henk Stapert, PhD is a serial entrepreneur and an all-round healthcare innovation manager. He held several positions in project, program and R&D management, in business development and currently in global innovation portfolio management. He has 15 years of expertise in building new healthcare businesses both via corporate venturing at Philips as well as via VC backed start ups. Two of his radical innovation programs have grown into successful businesses. The first one is the Idylla molecular diagnostics platform of Biocartis (Euronext, BCART) and the second one is Onvision, an ultrasound guidance and tracking platform, co-branded and marketed by both Philips and B. Braun.
Henk Stapert holds a master degree (1993) in Chemical Technology from the University of Twente and a PhD (1998) in Biomedical Engineering from the same university. After an award winning 2 years fellowship on smart drug delivery systems and photodynamic therapy at the University of Tokyo (1998), he joined Philips Research in 2000. He is a (co)inventor of over 25 granted patent applications and is a frequently invited speaker.
Henk likes to be in the heart of innovation and initiating & directing innovative programs that create solutions for the bigger challenges in healthcare, thereby playing an integral role in the company’s innovation portfolio, strategic roadmap and future growth.
In addition, he is a passionate team builder who finds satisfaction in inspiring people to a common, ambitious goal and a team player that takes the lead and responsibility when needed, but find a lot of satisfaction in coaching team members to empower their career development.
New Business Creation, and Scaling in a Corporate Organization.